Clinical Trials Browser

Phase 2 × Completed × Esophageal × Clear all

NCT02591784 2022-03-17

Nimotuzumab in Combination With Radiotherapy for Esophageal Cancer

Phase 2 Completed

Gastrointestinal

Esophageal